Connecticut § 20-618 (Formerly Sec. 21a-107). Repackaged drugs not considered misbranded, when.

Connecticut Statutes

§ 20-618 — (Formerly Sec. 21a-107). Repackaged drugs not considered misbranded, when.

Connecticut § 20-618

Title 20Professional and Occupational Licensing, Certification, Title Protection and Registration. Examining Boards

Ch. 400jPharmacy

This text of Connecticut § 20-618 ((Formerly Sec. 21a-107). Repackaged drugs not considered misbranded, when.) is published on Counsel Stack Legal Research, covering Connecticut primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Conn. Gen. Stat. § 20-618 (2026).

Text

Notwithstanding the provisions of section 21a-106 concerning misbranding of drugs or devices, a drug shall not be considered misbranded when repackaged by a pharmacy or an institutional pharmacy into stock packages for use within the pharmacy or the institutional pharmacy, provided the stock packages contain a label indicating the drug's name, strength, lot number, manufacturer and expiration date, if any.

Free access — add to your briefcase to read the full text and ask questions with AI

Notwithstanding the provisions of section 21a-106 concerning misbranding of drugs or devices, a drug shall not be considered misbranded when repackaged by a pharmacy or an institutional pharmacy into stock packages for use within the pharmacy or the institutional pharmacy, provided the stock packages contain a label indicating the drug's name, strength, lot number, manufacturer and expiration date, if any.

Legislative History

(P.A. 79-116, S. 2; P.A. 95-264, S. 39.) History: Sec. 19-226a transferred to Sec. 21a-107 in 1983; P.A. 95-264 made technical changes; Sec. 21a-107 transferred to Sec. 20-618 in 1997.